Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1318309 | 0.86 | — | — | |
| SCHEMBL1322155 | 0.84 | — | — | |
| SCHEMBL1322191 | 0.84 | — | — | |
| SCHEMBL1319158 | 0.83 | MAPT (0.32) | MAPTDRD2 | |
| SCHEMBL1321353 | 0.82 | RAB9A (0.30) | — | |
| SCHEMBL1318187 | 0.78 | — | — | |
| SCHEMBL1322453 | 0.76 | — | — | |
| SCHEMBL1319286 | 0.74 | NPC1 (0.33) | — | |
| SCHEMBL1321050 | 0.74 | NPC1 (0.30) | — | |
| SCHEMBL1321643 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2368896-B1 | Mono-indenyl transition metal compounds and polymerization therewith | EXXONMOBIL CHEM PATENTS INC (US) | 2016-08-24 | — | — | EP | disclosed |
| US-8058461-B2 | Mono-indenyl transition metal compounds and polymerization therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-11-15 | — | — | US | disclosed |
| EP-2368896-A1 | Mono-indenyl transition metal compounds and polymerization therewith | ExxonMobil Chemical Patents Inc. (US) | 2011-09-28 | — | — | EP | disclosed |
| US-20110213109-A1 | Mono-Indenyl Transition Metal Compounds and Polymerization Therewith | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110213109-A1 | Mono-Indenyl Transition Metal Compounds and Polymerization Therewith | ICMT, TERT, PIN1 | MAPT 103/4885DRD2 3458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.